Title here

Text here
 
Donate Now

MELANOMA RESEARCH ALLIANCE FOUNDATION Organization Name provided in the GuideStar Exchange* as of 01/10/2014: MELANOMA RESEARCH ALLIANCE FOUNDATION

Organization Name as listed in the IRS Business Master File as of 12/08/2014: MELANOMA RESEARCH ALLIANCE FOUNDATION

* The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

AKA  Melanoma Research Alliance; MRA
Washington, DC
GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

GuideStar Summary

&1002; GuideStar Exchange Committed to transparency ?
This organization is a Gold-level GuideStar Exchange participant, demonstrating its commitment to transparency.

Is this your nonprofit? Update your information today!
&1002; Registered with IRS Legitimacy information is available
&1002; Financial Data Annual Revenue and Expense data reported
&1002; Forms 990 2012, 2011, and 2010 Forms 990 filed with the IRS
&1002; Mission Objectives Mission Statement is available
&1002; Impact Summary Impact Summary from the nonprofit and Charting Impact Report are available
  No Personal Reviews available No Personal Reviews available | Write a Review

Basic Organization Information

MELANOMA RESEARCH ALLIANCE FOUNDATION Organization Name provided in the GuideStar Exchange* as of 01/10/2014: MELANOMA RESEARCH ALLIANCE FOUNDATION

Organization Name as listed in the IRS Business Master File as of 12/08/2014: MELANOMA RESEARCH ALLIANCE FOUNDATION

* The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
Also Known As: Melanoma Research Alliance; MRA
Physical Address: Washington, DC 20005 
EIN: 26-1636099
Web URL: www.CureMelanoma.org 
Blog URL: curemelanoma.wordpress.com/ 
NTEE Category: H Medical Research
H30 Cancer Research
U Science and Technology Research Institutes
U01 Alliance/Advocacy Organizations
Year Founded: 2007 
Ruling Year: 2009 
Top Funders: Public
Co-Founders
Corporate Partnerships


Sign in or create an account to see this organization's full address, contact information, and more!

Mission Statement

The mission of the MRA is to accelerate the pace of scientific discovery and its translation into effective options for patients – in prevention, diagnosis, prognosis, and treatment – in order to eliminate suffering and death due to melanoma.

Legitimacy Information

This organization is registered with the IRS.

This organization is required to file an IRS Form 990 or 990-EZ.

Institutional funders should note that an organization’s inclusion on GuideStar.org does not satisfy IRS Rev. Proc. 2011-33 for identifying supporting organizations.

Learn more about GuideStar Charity Check, the only pre-grant due diligence tool that is 100% compliant with IRS Rev. Proc 2011-33.

GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Annual Revenue & Expenses

(GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
January 2014)

Fiscal Year Starting: January 1, 2012
Fiscal Year Ending: December 31, 2012

Total Revenue $8,692,431
Total Expenses $9,337,447

Revenue & Expenses

(GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
January 2014)

Fiscal Year Starting: January 1, 2012
Fiscal Year Ending: December 31, 2012

Sign in or create an account to view this information from the GuideStar Exchange

The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Chart Illustration Revenue and Expense data from Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Back to Top »

Balance Sheet (IRS Form 990)

Chart Illustration Balance Sheet data from Forms 990 for Year 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Back to Top »
GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Forms 990 Received from the IRS Additional Information
IRS Form 990 is an annual document used by approximately one-third of all public charities to report information about their finances and operations to the federal government. GuideStar uses data from Form 990 to populate its database with financial information about nonprofit organizations. Posting Form 990 images on the GuideStar website is an ongoing process.

Sign in or create an account to view Form(s) 990 for 2012, 2011, 2010.

Chart Illustration Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Forms 990 Provided by the Nonprofit

Sign in or create an account to view Form(s) 990 for 2012.

Financial Statements

Chart Illustration Financial Statements for 2012, 2011, 2010 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Annual Reports

Sign in or create an account to view this information.

GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Leadership

(GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
January 2014)

Mrs. Wendy K.D. Selig

Profile:

Wendy K.D. Selig is president and CEO of the Melanoma Research Alliance (MRA), a public charity focused on finding and funding the most promising melanoma research worldwide that will accelerate progress toward a cure. Selig drives and manages MRA's strategic priorities, research portfolio, and day-to-day operations.   Prior to joining the MRA, Selig spent nearly a decade in leadership positions at the American Cancer Society (the Society) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), recently, as ACS CAN's vice president of external affairs & strategic alliances, where she built strategic partnerships with corporations, foundations, trade associations, and federal agencies. She oversaw the Society's campaign to ensure access to quality healthcare and chaired United for Medical Research focused on sustained federal support for biomedical research funding at the NIH. In 2008, Selig was appointed to serve on the National Cancer Institute Director's Consumer Liaison GrouSelig served on Capitol Hill as a top aide for U.S. Representative Porter J. Goss (R-FL), the House Rules Committee, and the House Permanent Select Committee on Intelligence.A native of Princeton, NJ, Selig is a magna cum laude graduate of Princeton University and holds a Master in Science (with distinction) from Northwestern University's Medill School of Journalism.

Board Chair (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
January 2014)

Sign in or create an account to view this information from the GuideStar Exchange

Board Co-Chair

This information has not been provided by the nonprofit. Click here if you are associated with this organization and want to provide this information.

Board of Directors (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
January 2014)

Sign in or create an account to view this information from the GuideStar Exchange

Board Leadership Practices (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
January 2014)
?

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section, which enables organizations and donors to transparently share information about essential board leadership practices.

Board Orientation & Education ?
Why does this matter? Without clarity around their responsibilities and expectations, board members are not positioned to succeed. They may find themselves challenged to fulfill their governance responsibilities or frustrated by the expectations that the organization has set for them. BoardSource recommends that every new board member participate in a formal orientation process, and that all board members sign a pledge or agreement committing to their board service and to all of the responsibilities and expectations that come with service. Ideally, board members also should participate in a formal governance training program prior to serving on a board.

Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations?
Response Not Provided
CEO Oversight ?
Why does this matter? Oversight and management of the chief executive is one of the board’s most important legal responsibilities. The CEO or executive director is the board's single employee, and - just like any other employer/employee relationship - regular and written assessment is critical to ensuring that the chief executive and board are communicating openly about goals and performance. BoardSource recommends that boards conduct formal, written reviews of their chief executives on an annual basis, which should include an in-person discussion with the chief executive and distribution of the written evaluation to the full board.

Has the board conducted a formal, written assessment of the chief executive within the past year?
Response Not Provided
Ethics & Transparency ?
Why does this matter? A commitment to handling conflicts of interests is essential to creating an organizational culture of transparency. Boards should create and follow a policy for identifying and handling conflicts of interest, whether real or perceived. BoardSource recommends that organizations review the conflict-of-interest statement and require signed disclosures from all board members and senior staff on an annual basis.

Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements within the past year?
Response Not Provided
Board Composition ?
Why does this matter? The best boards are composed of individuals who bring a variety of skills, perspectives, backgrounds, and resources to tackle the complex and strategic challenges confronting their organizations. BoardSource recommends that boards commit to diversity and inclusion by establishing written policies and practices, which include strategic and intentional recruitment of diverse board members, continual commitment to inclusivity, and equal access to board leadership opportunities.

Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership?
Response Not Provided
Board Performance ?
Why does this matter? Boards need to regularly assess their own performance. Doing so ensures that they are being intentional about how they govern their organization, which is a critical component of effective board leadership. BoardSource recommends that a board conduct a self-assessment of its performance a minimum of once every three years to ensure that it is staying on track with its roles and responsibilities.

Has the board conducted a formal, written self-assessment of its performance within the past three years?
Response Not Provided

Officers for Fiscal Year (IRS Form 990)

Chart Illustration Officers for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Highest Paid Employees & Their Compensation (IRS Form 990)

Chart Illustration Highest Paid Employee Data for 2012, 2011 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

People information was last updated by the nonprofit in January 2014

Click here if you are associated with this organization and want to provide updated information.

GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Programs

Program: Melanoma Research Funding (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
January 2014)

Budget:
$10,800,000
Category:
Skin Diseases
Population Served:
General Public/Unspecified
None
None

Program Description:

The MRA is focused on finding and funding the most promising melanoma research worldwide that will accelerate progress toward a cure. To date, MRA has awarded $48 million to 116 research programs to make transforming advances in the prevention, diagnosis and staging, and treatment of melanoma, including research in biological causes of carcinogenesis, skin screening, biomarkers, imaging, immunotherapy, molecularly targeted therapy, and combination therapy. MRA supports both individual investigator and collaborative team projects focused on translational, innovative research that will impact the prevention, diagnosis, staging, and treatment of melanoma in the near and intermediate future. The 2013-2014 Request for Proposals includes more detail about current funding opportunities. Young Investigator Awards aim to attract early career scientists with novel ideas into melanoma research, thereby recruiting and supporting the next generation of melanoma researchers. Young Investigators are scientists within four years of their first academic faculty appointment. A mentorship commitment from a senior investigator is required. Pilot Awards test potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues. Established Investigator Awards support senior investigators with an established record of scientific productivity and accomplishment and who are past the initial four years of their first academic faculty appointment. Team Science Award Programs are the centerpiece of the MRA research funding portfolio. This program fulfills one of MRA’s primary goals: to foster a collaborative research process. Multidisciplinary teams consist of Principal Investigators with complementary expertise who may be from the same institution, inter-institutional, and/or international institutions. Team science projects promote transformational melanoma research advances with the potential for rapid clinical translation. Partnership Awards are designed to facilitate interactions between sectors including industry and other nonprofit organizations. Development Awards are a subtype of a Pilot Award in which one year of funding is provided to test potentially transformative "high-risk, high-reward" ideas that do not have extensive preliminary data but would establish proof-of-concept. Investigators who are past the initial four years of their first academic faculty are eligible.

Program Long-Term Success:

Program Short-Term Success:

In just a few years of active research, significant progress has already been made. The productivity of funded investigators as a direct result of MRA awards has been high, as measured in tangible outcomes and in promising early research results. MRA is building a robust, collaborative melanoma research community focused on delivering effective results as quickly as possible.

Program Success Monitored by:

All proposals undergo rigorous peer review by the MRA Grant Review Committee, comprised of experts in diverse areas of translational cancer research. The GRC operates under guidelines that ensure objective review by the committee. Of note, GRC members who are Principal Investigators on applications do not participate in the review of any applications. Members who have other conflicts with specific proposals may not review or vote on such proposals. Final funding decisions are ratified by the MRA Board of Directors. Full-term funding is contingent upon review of annual progress reports and other oversight activities conducted by MRA.

Program Success Examples:

More than $46 million in additional research funding leveraged from other sources by MRA investigators. The majority of this funding was granted by two sources: U.S. National Institutes of Health and other foundations. 18 clinical trials supported by MRA to test promising agents alone and in combination for the treatment of metastatic melanoma. 17 patent applications filed for new technology, which have the potential to be developed into new tools or treatments for patients. More than 100 papers published in high-impact journals describing research results supported by MRA, which inform the scientific and clinical communities about promising new research so that others may build upon the results to help patients. More than 145 collaborations initiated and strengthened between academic, government, and industry scientists, which enhance sharing of information and fast-forwarding of the research. Approximately 450 presentations delivered by MRA investigators at medical and scientific meetings around the world, where research results are shared and the profile of MRA is enhanced.
GuideStar Exchange - Gold Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Reviews

Organization Data Available

Adobe PDF Format A GuideStar Premium Report in PDF format is available for this organization

Price for this Report: $125.00

This Premium Report includes:

  • Financial Data for
  • Financial Charts for
  • Forms 990 for
  • Forms 990T for
  • Audited Financial Statement for
  • Annual Reports for
  • Letter of Determination
  • Form 1023 / 1024
  • Board Members
  • Officer, Director and/or Highest Paid Employee data for


Learn more about GuideStar Premium